To evaluate the safety, efficacy, and population effectiveness/impact of a virus-like particle human papillomavirus vaccine over a 10-year period. This will include an evaluation of efficacy against HPV types not included in the vaccine formulation and a proof-of principle evaluation of efficacy at extracervical sites. To explore immunological responses associated with vaccination, immunological determinants of protection, and minimum protective levels associated with vaccination. To evaluate the impact of HPV vaccination on cytology and HPV DNA based screening programs. To evaluate the natural history of HPV types other than HPV-16/18 in a vaccinated population.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
N01CP11005-19-0-1
Application #
8429101
Study Section
Project Start
2001-04-30
Project End
2012-02-29
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$870,317
Indirect Cost
Name
Fundacion Inciensa
Department
Type
DUNS #
853088008
City
State
Country
Costa Rica
Zip Code